CommercialCoverageHigh impact
08.01.08t, Coverage of Anticancer Prescription Oral and Injectable Drugs and Biologics and Supportive Agents
Independence Blue Cross·Oncology, Pharmacy·Pharmacy
Effective date
Apr 30, 2025
We identified it
Jun 19, 2026
Summary
Policy 08.01.08t has been reissued effective 04/30/2025, governing coverage of anticancer prescription oral and injectable drugs, biologics, and supportive agents. The billing team must review the full policy text to identify specific coverage changes, billing code updates, prior authorization requirements, or documentation modifications that affect oncology drug claims.
Action Required
By 04/30/2025: Billing team must obtain and review the complete policy text from the provided URL. Identify all specific coverage criteria, prior authorization requirements, billing codes, and medical necessity documentation for anticancer drugs and supportive agents. Update billing software, prior authorization workflows, and provider education materials accordingly. Communicate changes to oncology providers and front desk staff. Failure to implement required changes will result in claim denials for anticancer drug claims.